论文部分内容阅读
药品是特殊商品。坚持文明生产、规范生产的核心是保证药品质量。药品质量的好坏直接关系到千家万户人的生命安危,关系到企业的兴衰。本文通过对一违反《药品管理法》案例的剖析看加强药品生产企业监督管理的重要性。 我市某制药厂于1989年7月12日生产肌苷注射液(批号890712)167000支,价值人民币29225元。分别销往本省及其它地区,在××市两家医院使用期间,发生70例不同程度的热原反应。经我市药品检验所按肌苷注射液质量标准检验,热原不符合规定。根据《药品管理法》第三十四条,认定该注射液为劣药。我市
Drugs are special products. Adhere to civilized production, standardize the core of production is to ensure the quality of medicines. The quality of medicines is directly related to the lives and safety of thousands of households and the rise and fall of the enterprises. This article through to a violation of “Drug Administration Law” case analysis to see the importance of strengthening drug regulatory supervision and management. A pharmaceutical factory in the city produced 167,000 inosine injection (lot number 890712) on July 12, 1989, worth RMB 29,225 yuan. Respectively, were sold to the province and other regions, the two hospitals in × × City, the use of 70 cases occurred in varying degrees pyrogen reaction. By the city drug testing by inosine injection quality standards, pyrogen does not meet the requirements. According to Article 34 of the “Drug Administration Law”, the injection is considered as inferior medicine. My city